#RareDiseaseDay highlights conditions affecting < 1 in 2000 people. Collectively, these diseases are not rare, affecting 1 in 17 people in the UK. Almost 1 in 5 cancers fall into this category. We support research into #Myeloma , #FollicularLymphoma , #PolycythemiaVera , #ITP & #RCC
Complications of Polycythemia Vera
#polycythemiavera #bloodclot #bloodclot s #dvt #spleen enlargement #spleen #heartattack #anavara #vkare #nigeria
#ASH23
#Polycythemiavera #Essentialthrombocythemia
-I like IPSET, including CV RF
-Is ROPEG > Hydrea 1L for PV
-Does molecular response and reduction in JAK2 Allele with ROPEG translate to disease modification?
Phlebotomies help reduce hematocrit (HCT) to <45% in #polycythemiavera (PV), but too frequent phlebotomies may exacerbate disease-related iron deficiency in patients.
Learn more about PV on our website: bit.ly/4aOg5B3
💡 #Polycythemiavera (PV) patients with the #JAK2 exon 12 mutation tend to be younger at the time of diagnosis compared to those with the #JAK2 V617F mutation.
#PVawareness #HealthMatters #MedicalAdvancements #FightPV
Individuals with the #JAK2 exon 12 mutation may be less responsive to traditional therapies, such as hydroxyurea, which are commonly used to control blood cell counts in #Polycythemiavera (PV) patients.
#JAK2 Mutation #PolycythemiaVera #JAK2 V617F #JAK2 Exon12 #BloodDisorders
Higher JAK2 V617F mutation burden (>25%) was associated with shorter #thrombosis -free survival in high-risk #polycythemiavera . Do you guys regularly check allele burden? #mpnsm #ISTH2023
December's “ #RareDisease of the Month' is #PolycythemiaVera , a chronic #BloodCancer that thickens the blood and increases the risk of blood clots.
To learn more, visit: cancer.gov/types/myelopro…
We're thrilled to announce an exclusive worldwide agreement w/ #RNAi pioneers Alnylam Pharmaceuticals and add to our pipeline a novel preclinical siRNA targeting TMPRSS6 as a potential disease-modifying treatment for patients w/ #PolycythemiaVera . Read the press release: investor.agios.com/news-releases/…
The #polycythemiavera market is primarily driven by the increasing incidence of gene mutations affecting blood cell development in the bone marrow
Read more:
digitaljournal.com/pr/news/imarc/…
#marketsize #markettrends #marketresearch #marketforecast #marketanalysis #healthcare #disease
Join us April 5th at 7:30am CST as we discuss #PolycythemiaVera with Dr. Ayalew Tefferi, MD.
A professor of #Hematology 🩸 and #IM at the Mayo Clinic since 2001, Dr. Tefferi's research has contributed invariably to our understanding of MPNs and other bone marrow disorders. 🔬
Out in NEJM rusfertide in Polycythemia vera - Fadi Haddad, MD
oncodaily.com/37585.html
#Cancer #NEJM #OncoDaily #Oncology #PolycythemiaVera #Cancer Care
A short clip outlining the mechanism of disease for Polycythemia Vera (PV), animated by MadMicrobe.
Explore more work by MadMicrobe Studios: buff.ly/32rPRE2
#polycythemiavera #animation #medical #3D #medical animation #cardiology #oncology #mechanismofaction #sciart
#PolycythemiaVera (PV) is one of a group of rare conditions called myeloproliferative neoplasms (MPNs), which cause the body to produce blood cells in an uncontrolled way. While available treatments help manage symptoms and lower complication risks, they do not cure the
A short clip by MadMicrobe outlining the mechanism of disease for PV (Polycythemia Vera).
Explore more work by MadMicrobe Studios: buff.ly/32rPRE2
#PV #polycythemiavera #medical #animation #medical animation #3D #medical animators #oncology #cellbiology #biology #sciart
👉👉👉It’s time to start re-thinking & re-imagining & really discussing a new era of endpoints, response criteria & what it means to achieve #DiseaseModification for patients with #PolycythemiaVera in modern targeted therapy era 📣 #MPNSM
ashpublications.org/blood/article/…
